WGO Graded Evidence: Malabsorption

Level: Clinical Trials: 15 Abstracts

Legend:   : Special Mention  : Important  : Very Important  : Key Development
	Effect of B-vitamin therapy on progression of diabetic nephropathy: a randomized controlled trial. House AA, Eliasziw M, Cattran DC, Churchill DN, Oliver MJ, Fine A, Dresser GK,Spence JD., JAMA. 2010 Apr 28;303(16):1603-9.
	Efficacy of ceftriaxone or meropenem as initial therapies in Whipple's disease. Feurle GE, Junga NS, Marth T., Gastroenterology. 2010 Feb;138(2):478-86; quiz 11-2. Epub 2009 Oct 29.
	Gluten causes gastrointestinal symptoms in subjects without celiac disease: adouble-blind randomized placebo-controlled trial. Biesiekierski JR, Newnham ED, Irving PM, Barrett JS, Haines M, Doecke JD,Shepherd SJ, Muir JG, Gibson PR., Am J Gastroenterol. 2011 Mar;106(3):508-14; quiz 515. Epub 2011 Jan 11.
	Parenteral fish-oil-based lipid emulsion improves fatty acid profiles and lipids in parenteral nutrition-dependent children. Le HD, de Meijer VE, Robinson EM, Zurakowski D, Potemkin AK, Arsenault DA, FallonEM, Malkan A, Bistrian BR, Gura KM, Puder M., Am J Clin Nutr. 2011 Sep;94(3):749-58. Epub 2011 Jul 20.
	Enzyme therapy for management of coeliac disease. HJ Cornell, FA Macrae, J Melny, CJ Pizzey, F Cook, S Mason, PS Bhathal, T Stelmasiak, Scand J Gastroenterol. 2005 Nov:1304-12
	Glucagon-like peptide-2: update of the recent clinical trials. PB Jeppesen, Gastroenterology. 2006 Feb:S127-31
Supplementary evidence:
	Effects of a supplementary diet with specially processed cereals in patients with short bowel syndrome. Pagoldh M, Eriksson A, Heimtun E, Kvifors E, Sternby B, Blomquist L, Lapidus A, Suhr O, Lange S, Karlbom U, Nordström D, Rettrup B, Eur J Gastroenterol Hepatol. 2008 Nov;20(11):1085-93
	Antiendomysial and antihuman recombinant tissue transglutaminase antibodies in the diagnosis of coeliac disease: a biopsy-proven European multicentre study. P Collin, K Kaukinen, H Vogelsang, I Korponay-Szabó, R Sommer, E Schreier, U Volta, A Granito, L Veronesi, F Mascart, A Ocmant, A Ivarsson, C Lagerqvist, A Burgin-Wolff, F Hadziselimovic, RI Furlano, MA Sidler, CJ Mulder, MS Goerres, ML Mearin, MK Ninaber, E Gudmand-Høyer, E Fabiani, C Catassi, H Tidlund, L Alainentalo, M Mæki, Eur J Gastroenterol Hepatol. 2005 Jan:85-91
	Evidence for increased apoptosis of duodenal intraepithelial lymphocytes in cow's milk sensitive enteropathy. MT Augustin, J Kokkonen, TJ Karttunen, J Pediatr Gastroenterol Nutr. 2005 Mar:352-8
	Given capsule endoscopy in celiac disease: evaluation of diagnostic accuracy and interobserver agreement. R Petroniene, E Dubcenco, JP Baker, CA Ottaway, SJ Tang, SA Zanati, CJ Streutker, GW Gardiner, RE Warren, KN Jeejeebhoy, Am J Gastroenterol. 2005 Mar:685-94
	Intestinal permeability in long-term follow-up of patients with celiac disease on a gluten-free diet. DR Duerksen, C Wilhelm-Boyles, DM Parry, Dig Dis Sci. 2005 Apr:785-90
	Nutritional supplements used in weight-reduction programs increase intestinal gas in persons who malabsorb lactose. FL Suarez, LM Zumarraga, JK Furne, MD Levitt, J Am Diet Assoc. 2001 Dec:1447-52
	Oats to children with newly diagnosed coeliac disease: a randomised double blind study. L H&oeig;gberg, P Laurin, K Fælth-Magnusson, C Grant, E Grodzinsky, G Jansson, H Ascher, L Browaldh, JA Hammersj&oeig;, E Lindberg, U Myrdal, L Stenhammar, Gut. 2004 May:649-54
	Screening of the adult population in Iran for coeliac disease: comparison of the tissue-transglutaminase antibody and anti-endomysial antibody tests. MR Akbari, A Mohammadkhani, H Fakheri, M Javad Zahedi, B Shahbazkhani, M Nouraie, M Sotoudeh, R Shakeri, R Malekzadeh, Eur J Gastroenterol Hepatol. 2006 Nov:1181-6
	The safety, tolerance, pharmacokinetic and pharmacodynamic effects of single doses of AT-1001 in coeliac disease subjects: a proof of concept study. BM Paterson, KM Lammers, MC Arrieta, A Fasano, JB Meddings, Aliment Pharmacol Ther. 2007 Sep 1:757-66